Oculus Innovative Sciences, Inc. Introduces Two New Microcyn® Advanced Wound Care Products For U.S. Prescription Wound Care Market

Published: Jan 07, 2014

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

PETALUMA, Calif., Jan. 7, 2014 (GLOBE NEWSWIRE) -- Oculus Innovative Sciences, Inc. (Nasdaq:OCLS), a global healthcare company that designs, manufactures and markets prescription and non-prescription products in 31 countries, today introduced two new products to its U.S. family of Microcyn®-based advanced wound care products.

Help employers find you! Check out all the jobs and post your resume.

Back to news